These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10155297)

  • 41. [Clinical study of S 6472 granule preparation (sustained-release cefaclor) in chronic respiratory airway infections].
    Odagiri S; Matsunaga K; Suzuki K; Murohashi K; Numata H; Takahashi K; Yamaki I; Ishii S
    Jpn J Antibiot; 1988 Sep; 41(9):1325-33. PubMed ID: 3241332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cefaclor--summary of clinical experience.
    Kammer RB; Short LJ
    Postgrad Med J; 1979; 55 Suppl 4():93-9. PubMed ID: 548945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapy of acute bacterial infections with cefaclor in a pediatric population: an open assessment.
    Iancu TC; Sinoff G
    Isr J Med Sci; 1983 Nov; 19(11):998-1000. PubMed ID: 6662693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical examination of S 6472 (sustained release preparations of cefaclor on chronic respiratory tract infection].
    Hayashi I; Ohnuma K
    Jpn J Antibiot; 1988 Sep; 41(9):1313-8. PubMed ID: 3241330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of amoxycillin and cefaclor on the colonization resistance of oropharynx.
    van Saene HK; Willems FT; Zweens J
    Scand J Infect Dis Suppl; 1983; 39():97-9. PubMed ID: 6359384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can roxithromycin and betamethasone induce acute pancreatitis? A case report.
    Renkes P; Petitpain N; Cosserat F; Bangratz S; Trechot P
    JOP; 2003 Sep; 4(5):184-6. PubMed ID: 14526130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activity of roxithromycin against respiratory pathogens.
    Facinelli B; Varaldo PE
    J Chemother; 1991 Jan; 3 Suppl 1():33-5. PubMed ID: 12041781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Roxithromycin-induced toxic epidermal necrolysis.
    Das S; Mondal S; Dey JK
    Ther Drug Monit; 2012 Aug; 34(4):359-62. PubMed ID: 22777150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comment: cost-effectiveness of macrolides in lower respiratory tract infections.
    Renz CL; Ashraf T
    Ann Pharmacother; 2000 Oct; 34(10):1206-7. PubMed ID: 11054992
    [No Abstract]   [Full Text] [Related]  

  • 50. [Is it caused by the medication? Sweet syndrome].
    Thalmann H; Müller S; Müller JB
    MMW Fortschr Med; 2013 Jun; 155(12):5, 53. PubMed ID: 23923292
    [No Abstract]   [Full Text] [Related]  

  • 51. [The respiratory system: anti-infectious strategy in 1984].
    LARC Med; 1984 Nov; 4(9):566-7. PubMed ID: 6513712
    [No Abstract]   [Full Text] [Related]  

  • 52. How should we evaluate new anti-infectives for respiratory tract infections?
    Paladino JA
    Can Respir J; 1999; 6 Suppl A():31A-4A. PubMed ID: 10202231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of Runac in patients with infections of the lower respiratory tract].
    Popovac D; Plavsić Z; Filipović M
    Plucne Bolesti; 1990; 42(3-4):188-90. PubMed ID: 2101948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical studies on te concentration of cefaclor in sera and lung tissues of patients with respiratory diseases].
    Imaizumi M; Kajita M; Fujita K; Niimi T; Kamiya I; Takahashi T; Asaoka M; Abe T
    Jpn J Antibiot; 1986 Oct; 39(10):2754-60. PubMed ID: 3806958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibiotics for common respiratory infections.
    Owen S
    Aust Fam Physician; 1995 Jul; 24(7):1368-9. PubMed ID: 7661790
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical trials on pediatric lower-respiratory-tract infection: results and comments with cefetamet pivoxil.
    Paupe J; Sarbeji M; Scheinmann P; Delacourt C; Sorin M
    Chemotherapy; 1992; 38 Suppl 2():29-32. PubMed ID: 1516462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost effectiveness of amoxicillin for lower respiratory tract infections in primary care: an economic evaluation accounting for the cost of antimicrobial resistance.
    Oppong R; Smith RD; Little P; Verheij T; Butler CC; Goossens H; Coenen S; Moore M; Coast J
    Br J Gen Pract; 2016 Sep; 66(650):e633-9. PubMed ID: 27402969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nail pigmentation due to roxithromycin.
    Dawn G; Kanwar AJ; Dhar S
    Dermatology; 1995; 191(4):342-3. PubMed ID: 8573939
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparative clinical efficacy of cefetamet pivoxil in lower respiratory tract infection.
    Grassi GG
    Drugs; 1994; 47 Suppl 3():35-42. PubMed ID: 7518765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determination of antimicrobial activity of Cefaclor on common respiratory tract pathogens in Pakistan.
    Ahmed A; Hafiz S; Rafiq M; Tariq N; Abdulla EM; Hussain S; Azim R; Siddiqui SJ; Awan A; Khan KZ; Fareed A
    J Pak Med Assoc; 2002 Jan; 52(1):7-11. PubMed ID: 11963587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.